Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Silverman

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|December 6, 2012
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristineJeffrey A Silverman, Steven R Deitcher
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 29, 2008
Hemoglobin köln and pregnancyVincent Y T Cheung, Jeffrey A Silverman
Obstetrics and Gynecology|November 2, 2004
The appropriateness of red blood cell transfusions in the peripartum patientJeffrey A Silverman, Jon Barrett, Jeannie L Callum
Journal of Clinical Pharmacology|August 3, 2013
Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemiaJeffrey A Silverman, Laurie Reynolds, Steven R Deitcher
Clinical Lymphoma, Myeloma & Leukemia|November 21, 2013
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapyLawrence D Kaplan, Steven R Deitcher, Jeffrey A Silverman, et al.
Journal of Clinical Pharmacology|December 29, 2017
Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal ImpairmentYan Xin, Jun Kawashima, Winnie Weng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Metabolism of (+)-1,4-dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid (voreloxin; formerly SNS-595), a novel replication-dependent DNA-damaging agentMarc J Evanchik, Darin Allen, Josh C Yoburn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 20, 2004
Successful pregnancy with nocturnal hemodialysisAzim S Gangji, Rory Windrim, Shital Gandhi, et al.
Journal of Clinical Pharmacology|July 3, 2026
Human Disposition, Metabolism, and Excretion of Sevasemten (EDG-5506), a Selective Modulator of Fast Myosin in Healthy VolunteersMolly Madden, Marc Evanchik, Jonathan Lane, et al.
Clinical and Translational Science|March 17, 2023
Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparaginase (JZP458) in patients with acute lymphoblastic leukemiaTong Lin, Tajhia Whigham, Indrasiri Fernando, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|December 6, 2012
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristineJeffrey A Silverman, Steven R Deitcher
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 29, 2008
Hemoglobin köln and pregnancyVincent Y T Cheung, Jeffrey A Silverman
Obstetrics and Gynecology|November 2, 2004
The appropriateness of red blood cell transfusions in the peripartum patientJeffrey A Silverman, Jon Barrett, Jeannie L Callum
Journal of Clinical Pharmacology|August 3, 2013
Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemiaJeffrey A Silverman, Laurie Reynolds, Steven R Deitcher
Clinical Lymphoma, Myeloma & Leukemia|November 21, 2013
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapyLawrence D Kaplan, Steven R Deitcher, Jeffrey A Silverman, et al.
Journal of Clinical Pharmacology|December 29, 2017
Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal ImpairmentYan Xin, Jun Kawashima, Winnie Weng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Metabolism of (+)-1,4-dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid (voreloxin; formerly SNS-595), a novel replication-dependent DNA-damaging agentMarc J Evanchik, Darin Allen, Josh C Yoburn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 20, 2004
Successful pregnancy with nocturnal hemodialysisAzim S Gangji, Rory Windrim, Shital Gandhi, et al.
Journal of Clinical Pharmacology|July 3, 2026
Human Disposition, Metabolism, and Excretion of Sevasemten (EDG-5506), a Selective Modulator of Fast Myosin in Healthy VolunteersMolly Madden, Marc Evanchik, Jonathan Lane, et al.
Clinical and Translational Science|March 17, 2023
Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparaginase (JZP458) in patients with acute lymphoblastic leukemiaTong Lin, Tajhia Whigham, Indrasiri Fernando, et al.
Pageof 4